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1684-1182/Copyright ª 2015, TaiwanAbstract Background/Purpose: Screening for vancomycin-resistant enterococci (VRE) by cul-
ture takes days to generate results, while polymerase chain reaction (PCR) testing directly
from clinical specimens lacks specificity. The aims of this study were to develop a real-time
PCR to detect and identify Enterococcus faecium, Enterococcus faecalis, and vanA and vanB
genes, and to evaluate the impact of this PCR on test-reporting times when performing it
directly from suspect VRE isolates present on screening chromogenic media.
Methods: The tetraplex PCR primers were designed to amplify E. faecium, E. faecalis, and vanA
and vanB genes, with melt-curve analysis of PCR products. Following analytical and clinical vali-
dation of the molecular assay, PCR testing was performed for target colonies present on VRE
chromogenic media. PCR results were evaluated against conventional phenotypic identification
and susceptibility testing, with the time to result being monitored for both modalities.
Results: A total of 519 colonies from clinical specimens were tested concurrently by real-time
PCR and phenotypic methods. In all, 223 isolates were identified with phenotypic vancomycin
resistance (vanA, n Z 108; vanB, n Z 105; non-vanA/vanB Z 10), with complete agreement
between PCR and phenotypic testing for vancomycin-resistant E. faecium and E. faecalis.
The majority (88.6%) of PCR results were reported, on average, 24.8 hours earlier than those
of phenotypic testing, with 68% reduction in total costs.
Conclusion: The use of culture on selective media, followed by direct colony PCR confirmation
allows faster and economical VRE screening.
Copyright ª 2015, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.of Laboratory Medicine, Changi General Hospital, 2 Simei Street 3, Singapore, 529889, Singapore.
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+ MODELIntroductionSince their emergence in the early 1980s, vancomycin-
resistant enterococci (VRE) have become significant health
care-acquired global pathogens. Asymptomatic coloniza-
tion of patients and residents of long-term care facilities
has been demonstrated to be frequent,1 and this may result
in widespread environmental contamination.2 Active sur-
veillance for VRE detects asymptomatic carriers, with the
potential to reduce in-hospital transmission.3 However,
laboratory methods for the detection of VRE vary in per-
formance. Routine culture on standard media with pheno-
typic identification and susceptibility testing takes 2e4
days for results to become available. Chromogenic selec-
tive media have improved the specificity and sensitivity of
screening cultures,4 but provide only presumptive identifi-
cation of VRE, requiring confirmation by standard pheno-
typic methods.
Direct molecular detection of VRE from clinical speci-
mens has been evaluated by multiple studies using con-
ventional polymerase chain reaction (PCR),5 real-time PCR,6
and commercial molecular kits.7,8 Although PCR assays have
high clinical sensitivity, clinical specificity is lower and
generally confounded by the presence of nonenterococcal
enteric bacteria that possess the vanB gene.5,7,8
Combination of primary culture on chromogenic media
and rapid confirmation of suspect colonies by PCR has the
potential to provide both improved specificity and faster
reporting times. The aims of this study were to develop a
real-time PCR to detect and identify Enterococcus faecium,
Enterococcus faecalis, and vanA and vanB genes from
bacterial colonies, and to evaluate the impact of this PCR
on test reporting times when performing it directly from
suspect colonies present on chromogenic media.
Methods
This study was performed in an 800-bed tertiary referral
hospital that provides acute medical and surgical services.
VRE screening was routinely performed for inpatients on
renal dialysis therapy and inpatients with a length of hos-
pitalization exceeding 14 days. Inpatient contacts of known
or identified carriers with VRE were also screened. Perianal
or rectal swabs were plated onto chromogenic agar (Bril-
liance VRE agar; Oxoid, Basingstoke, UK) and enterococcal
agar containing 6 mg/L of vancomycin (VRE Agar; Oxoid,
Basingstoke, UK). Media were incubated at 35C in ambient
air for 40e48 hours, and visually inspected for suspected
colonial growth after 18e24 hours and 40e48 hours of in-
cubation, with subsequent confirmatory test performed at
the first visible growth. Suspected VRE colonies on either
medium were subcultured to nonselective media (Trypti-
case Soy agar with 5% Sheep Blood; BD, Franklin Lakes, New
Jersey, USA) for phenotypic identification and susceptibility
testing (Vitek ID-GP and AST-P67; BioMe´rieux, Marcy
l’Etoile, France).
The real-time PCR assay was a multiplex reaction with
primers targeted at the ddl gene in E. faecium and E.
faecalis,9 with a second primer set targeted at the vanA
and vanB genes that mediate vancomycin resistance in
enterococci.10 PCR reaction was performed in 20 mL volumePlease cite this article in press as: Tan TY, et al., Faster and economica
of chromogenic agar and real-time polymerase chain reaction, Jou
dx.doi.org/10.1016/j.jmii.2015.08.003containing 10 mL of 2 MeltDoctor HRM Master Mix (with
SYTO-9 dye; Life Technologies, Singapore) and primers
(0.2 mm/L of E. faecium forward/reverse primer each,
0.3 mm/L of E. faecalis forward/reverse primer each,
0.3 mm/L of vanA and vanB common forward primer,
0.15 mm/L of vanA reverse primer, and 0.4 mm/L of vanB
reverse primer). The PCR reaction was performed on a real-
time thermocycler (CFX96; Bio-Rad, Hercules, California,
USA) with the following cycling conditions: preheated at
95C for 10 minutes and then 35 cycles at 95C for 30 sec-
onds, 56C for 30 seconds, and 72C for 45 seconds. The
amplification cycles were followed by a melting cycle from
65C to 90C with incremental temperature escalation at a
rate of 0.2C every 5 seconds. The presence of targeted
PCR products was determined by standard melt-curve
analysis; presence of specific melt peaks indicated the
presence of the targeted genes (Table 1).
The real-time PCR was developed in two phases. In the
first phase, the analytical sensitivity and specificity of
species component of the real-time assay were assessed
against a test panel consisting of 35 bacterial strains (16
different bacterial genera, including 5 different entero-
coccal species). Analytical sensitivity of the vanA and vanB
gene components was tested using four known strains of
vancomycin-resistant E. faecium and E. faecalis from
external proficiency testing schemes, with the resistance
gene component confirmed by conventional PCR.11 In the
second phase, clinical specificity testing for the real-time
PCR was evaluated using 203 bacterial isolates taken
directly from primary VRE culture media. Speciation results
from the real-time PCR were compared against phenotypic
identification. The presence of the vanA or vanB gene
confirmed by the real-time assay was interpreted as an
indication of vancomycin resistance, and this was
compared against phenotypic susceptibility testing, while
the specific van genotype results were compared against
the results of conventional PCR11 (Figure 1).
Following analytical and clinical validation, the real-
time PCR assay was introduced for routine clinical testing
(Figure 1). PCR was performed directly from suspected
colonies present on screening media. If only a single colony
was present on primary culture, PCR testing was performed
the next day from the subcultured isolate. A single bacte-
rial colony was inoculated directly from culture media into
100 mL of molecular-grade water and vortexed. The sus-
pension (2 mL) was used as the template for PCR testing.
Conventional phenotypic testing was performed in parallel,
as previously described. Molecular testing was available
from Monday to Friday, while phenotypic testing was
available from Monday to Saturday. The time to results for
PCR and phenotypic testing were taken, respectively, as
the time when the PCR result was available, and the time
when phenotypic identification and susceptibilities were
available.
The cost of VRE identification was based on the direct
cost of consumables used for testing. The time to perform a
single test was calculated by noting the actual hands-on
time required for both phenotypic or molecular testing, and
recording the number of isolates tested per batch of
testing. Incubation time and PCR cycling time were not
included for this calculation. The test time required for
each isolate was the total hands-on time required for eachl screening for vancomycin-resistant enterococci by sequential use
rnal of Microbiology, Immunology and Infection (2015), http://
Table 1 Multiplex real-time PCR used for differentiation of Enterococcus species and van A/B genotypes.
Oligonucleotide 50e30 sequence Target gene Melting peak Tm (C;  1 SD)
Van AB-Aus-F GTAGGCTGCGATATTCAAAGC vanA/B NA
Van A-Aus-R CGATTCAATTGCGTAGTCCAA vanA 80.2 ( 0.15)
Van B-Aus-R GCCGACAATCAAATCATCCTC vanB 83.0 ( 0.17)
Enterococcus faecalis-HRM-F GTGGCTTAAGTCGCTGTGAT ddlE. faecalis 73.2 ( 0.2)
E. faecalis-HRM-R AGGCATGGTGTTCAATTCAT
E. faecium-HRM-F TTTACAAGCTGCTGGTGTGC ddlE. faecium 75.4 ( 0.19)
E. faecium-HRM-R AACCCATATTCGCAGGTTTG
NA Z not available; PCR Z polymerase chain reaction; SD Z standard deviation.
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Testing time was measured for five separate batches of
testing, and the average testing time per isolate was
calculated. For both test methods, the costs of reagents
and consumables were calculated for each test, which
included the cost of appropriate positive and negative
controls for each batch of molecular test. Prices were
estimated in Singapore dollars (SGD) and converted to
United States dollars (USD), based on an exchange rate of 1
SGD Z 0.78 USD.
Results
The analytical sensitivity and specificity of the real-time
PCR assay for identification of E. faecium, E. faecalis, and
vanA and vanB genes was 100%, when evaluated against the
test panel. A total of 203 clinical isolates were phenotypi-
cally identified as E. faecalis (n Z 38), E. faecium
(n Z 141), and nonenterococcal isolates (n Z 24), with 55
isolates identified as VRE. The clinical sensitivity and
specificity of the real-time PCR was 100% for the evaluated
203 clinical isolates, with no discordant results for either
bacterial speciation or vancomycin resistance. Conven-
tional PCR performed on the 55 VRE isolated demonstrated
the presence of the vanA gene in 23 isolates and the vanB
gene in 32 isolates. There was 100% agreement between
conventional PCR and real-time PCR for differentiation of
the van genotypes.
A total of 519 routine clinical specimens with suspect
colonies growing on screening agar were tested concur-
rently with real-time PCR and standard phenotypic
methods. Of these specimens, 296 were negative for VRE
(vancomycin-susceptible Enterococcus spp., n Z 295;
Streptococcus durans, n Z 1). The remaining 223 speci-
mens were positive, by phenotypic testing, for vancomycin-
resistant Enterococcus species (E. faecium, n Z 208; E.
faecalis, n Z 4; Enterococcus gallinarum, n Z 9; Entero-
coccus casseliflavus, n Z 1; and Enterococcus avium,
n Z 1). There was complete concordance for speciation of
E. faecalis and E. faecium when PCR results were compared
with the results of phenotypic testing. VanA/B genes were
present in 213 isolates. One enterococcal isolate was pos-
itive, by PCR, for the vanA gene only and negative for E.
faecium/E. faecalis genes, and this was phenotypically
identified as vancomycin-resistant E. avium by Vitek ID-GP
(Table 2). The presence of phenotypic glycopeptide resis-
tance was concordant with the presence of vanA/B genes
by real-time PCR, while conventional PCR and real-timePlease cite this article in press as: Tan TY, et al., Faster and economica
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dx.doi.org/10.1016/j.jmii.2015.08.003PCR showed complete agreement for the differentiation
of the vanA and vanB genes.
For all tested samples, PCR results were available earlier
than the phenotypic testing results (mean 21.6 hours;
range, 31.2e91.2 hours). Of all PCR results, 460 (88.6%)
were available sooner than phenotypic results, and these
results were available, on average, 24.8 hours before
phenotypic testing results were available. For the remain-
ing 59 (11.4%) tests, PCR results were available later than
phenotypic results by an average of 11.5 hours.
Technologist hands-on time for each tested isolate was
4.0 minutes for phenotypic testing and 3.6 minutes for
molecular testing. The cost of consumables and reagents
per test was 18.00 USD for phenotypic testing, compared
with 5.80 USD for molecular testing.Discussion
Screening for carriers of VRE has been demonstrated to both
reduce cross-transmission within health-care institutions
and improve identification of unrecognized carriers.12 Cul-
ture methods perform well, but require relatively long
testing and reporting times. PCR detection of Enterococcus-
specific genes and van gene determinants directly from
clinical specimens has been evaluated in multiple studies,
with varying results. In general, detection of the vanA gene
demonstrates good specificity for the presence of VRE, but
specificity for the vanB gene is lower.7,13,14
Other studies have previously demonstrated the tech-
nical feasibility of performing VRE detection from colonial
growth following standard culture. Palladino and col-
leagues6,15 initially used fluorescence resonance energy
transfer (FRET)-based probes from plate culture and then
extended this to direct testing from enrichment broths. A
second study performed DNA extraction from enrichment
broths, followed by the use of a commercial kit.16 This
study differed from the preceding ones by the use of
chromogenic agar for primary screening of VRE from clinical
specimens, with suspect colonial growth confirmed by real-
time PCR. Our aims were to design a real-time PCR method
that was easy, quick to perform, and of low cost, and
improved the time to result. We achieved this by using a
direct colony extraction method (reducing the cost of
extraction consumables and hands-on time, and negating
the need for expensive automated DNA extraction tech-
nology) and melt-curve analysis rather than more expensive
probe-based methodologies. The study methods usedl screening for vancomycin-resistant enterococci by sequential use
rnal of Microbiology, Immunology and Infection (2015), http://
Figure 1. Validation and clinical implementation of real-time PCR in conjunction with culture. a Isolates tested: Enterococcus
faecium vanA (n Z 22), E. faecium vanB (n Z 32), E. faecalis vanA (n Z 1), vancomycin-susceptible E. faecium (n Z 87),
vancomycin-susceptible E. faecalis (n Z 37), nonenterococci (n Z 24). b Isolates tested: E. faecium vanA (n Z 103), E. faecium
vanB (n Z 105), E. faecalis vanA (n Z 4), E. avium vanA (n Z 1), vancomycin-susceptible E. faecium (n Z 198), vancomycin-
susceptible E. faecalis (n Z 91), other enterococci (n Z 16), other streptococci (n Z 1). cPCR Z conventional polymerase
chain reaction; PCR Z polymerase chain reaction; VRE Z vancomycin-resistant enterococci.
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Table 2 Isolation of vancomycin-resistant Enterococcus
species and detection of vanA/vanB genes by real-time PCR
following implementation of assay.
Species
Van gene by real-time PCR





Enterococcus faecium 103 105
Enterococcus gallinarum 9
Total 108 105 10
PCR Z polymerase chain reaction.
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reporting times and reducing test costs.
This method has some limitations. As PCR testing is not
typically available on weekends, phenotypic testing may
generate earlier results for a proportion of cases (11% of
tests, in this study). The real-time PCR is restricted to the
detection of the vanA and vanB genes, and does not detect
the presence of either the intrinsic vanC gene of E. casse-
liflavus or E. gallinarum, or the other newly described
transmissible van genes.17 The significance of potentially
missing non-vanA/vanB genes will depend on the local
epidemiology of circulating genes in VRE. In general, the
vanA and vanB determinants remain the most common
causes of acquired vancomycin resistance in E. faecium and
E. faecalis. Finally, analysis of cost is always subject to
regional prices, and each individual laboratory needs to
evaluate cost effectiveness of any test method based on
local data.
Matrix Assisted Laser Desorption/Ionization-Time of
Flight (MALDI-TOF) MS is potentially useful for rapid speci-
ation. However, identification of the species may be
dependent on the culture media from which the colony is
tested,18 and the accuracy of MALDI-TOF identification
directly from chromogenic media would require validation.
In addition, growth of Enterococcus species on VRE-
selective chromogenic media still requires confirmation of
vancomycin resistance, as most media lack sufficient
specificity. For example, in the evaluation of VRE Brilliance
media by Ongut and colleagues,19 only 20 out of 52 isolates
with positive suspect growth on the media were confirmed
as true VRE.
In summary, VRE screening on selective media followed
by PCR confirmation of suspect VRE isolates allows positive
results to be available 24 hours earlier than conventional
phenotypic testing methods.Conflicts of interest
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